|
CD46 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.997330E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.718100E-02 |
| Stage1-vs-Stage3 |
1.050000E-04 |
| Stage1-vs-Stage4 |
1.26600000038835E-07 |
| Stage2-vs-Stage3 |
1.281830E-03 |
| Stage2-vs-Stage4 |
1.554420E-04 |
| Stage3-vs-Stage4 |
2.225200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62481139653892E-12 |
| Normal-vs-AfricanAmerican |
2.03800309961366E-11 |
| Normal-vs-Asian |
3.143400E-03 |
| Caucasian-vs-AfricanAmerican |
8.880800E-01 |
| Caucasian-vs-Asian |
7.505800E-01 |
| AfricanAmerican-vs-Asian |
7.110200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.691400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.79660003435589E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
6.141100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.393400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.251000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.831200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.168400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.510800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.412800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.068830E-01 |
| Normal-vs-Grade 2 |
2.37176944750672E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
6.253900E-02 |
| Grade 1-vs-Grade 3 |
6.44659999999853E-05 |
| Grade 1-vs-Grade 4 |
1.576100000511E-07 |
| Grade 2-vs-Grade 3 |
1.218360E-04 |
| Grade 2-vs-Grade 4 |
9.41939859444574E-11 |
| Grade 3-vs-Grade 4 |
8.22050000000019E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.04372107915196E-12 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.61774999999365E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
5.97610000374615E-08 |
| N0-vs-N1 |
1.712960E-01 |
|
|
